CTOs on the Move

EyePoint Pharmaceuticals

www.eyepointpharma.com

 
EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
David Vario
Vice President Of Quality Profile
Said Saim
Chief Technology Officer Profile

Funding

EyePoint Pharmaceuticals raised $29M on 10/02/2018
EyePoint Pharmaceuticals raised $15.7M on 01/03/2021
EyePoint Pharmaceuticals raised $45M on 03/09/2022

Similar Companies

MedSym Solutions

MedSym Solutions is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Assembly Biosciences

Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.

Lerman and Son Orthotics and Prosthetics

Lerman and Son Orthotics and Prosthetics is a Beverly Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthcare Data Experts

Healthcare Data Experts is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fayette Companies

Fayette Companies is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Peoria, IL. To find more information about Fayette Companies, please visit www.fayettecompanies.org